Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · operational-macro

J&J sets mid-2027 target for orthopedics spinoff, as Q3 medtech sales miss estimates

13 October 2026 · By · Wire by Fusion42

Published

13 October 2026

Topic

operational-macro

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at massdevice.com →

◆ Verified

Fusion42 · 13 October 2026 · Fusion42 review

Johnson & Johnson plans to spin off its DePuy Synthes orthopedics unit by mid-2027, amid Q3 medtech sales that fell short of analyst expectations due to international headwinds and restructuring efforts.

This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it.

◆ ◆ The Wire takeaway

Orthopedics founders should prepare for changes in market access as J&J spins out DePuy Synthes, opening a door for new and existing players to capture orphaned customers and partnerships in this pure-play segment.

◆ Coverage

2 sources · 13 Oct 2026

◆ Related on Wire

◆ Topics

Medtechorthopedicsspinoffmedtechsales-misscorporate-restructuring